2025 · Journal of clinical microbiology · open access
Sensitivity and specificity of the Cobas Liat CT/NG/MG nucleic acid test in a clinical laboratory setting and point-of-care location
Van Der Pol et al.
The finding, in our words
The Cobas Liat CT/NG/MG nucleic acid amplification test achieved 97% specificity for chlamydia, gonorrhoea, and mycoplasma from self-collected urine and vaginal swabs at point-of-care, with sensitivity of at least 92% for most specimen types. Sensitivity was modestly lower for female urine (77–87%), yet the 20-minute turnaround time and ease of use support rapid, decentralised STI screening and reduced empiric treatment.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.